Gut Guide Oy

Eveliina Munukka

Annika Mayra-Makinen

Annika MÄYRÄ

Annika MÄYRÄ-MÄKINEN

The invention is based on a correlation observed between serotonin level and intestinal flora. The invention relates to a relative proportion of bifidobacteria in the intestine and in particular to a product increasing the ratio of bifidobacteria to Clostridia, to be used for raising the serotonin level. The invention also relates to a method for estimating a health risk associated with serotonin depletion by determining a relative proportion between bifidobacteria or Clostridia in the intestine or their ratio to one another. The invention further relates to a method for selecting a form of therapy for raising the serotonin level by determining a relative proportion between bifidobacteria or Clostridia in the intestine or their ratio to one another.

Raising and diagnosing of serotonin level

The invention is based on a correlation observed between visceral fat and gut flora. The invention relates to a product increasing the relative proportion ofin the intestines and to be used for preventing formation of visceral fat or for reducing the amount thereof in the body. In particular, the product increases the ratio ofto. The invention also relates to determining visceral fat in the body by determining the relative proportion oforor their ratio to each other in the intestines. The invention further relates to a method for estimating, in the same manner, the health risk associated with obesity.

Growing community of inventors

Turku, Finland

Eveliina Munukka